Search
for
Sort by
Research 301–330 of 1000+
- Female Adolescent Hair Disorders
- Secondary cicatricial and other permanent alopecias
- Topical application of synthetic melanin promotes tissue repair
- Skin manifestations of chronic kidney disease
- Dermatological Illnesses of Immigrant Poultry-Processing Workers in North Carolina
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Anticonvulsant-Induced Cutaneous Reactions
- A review on laser and light-based therapies for alopecia areata
- Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis
- Medicinal Plants and their Constituents in the Treatment of Acne vulgaris
- AROMA THERAPY: AN ART OF HEALING
- Dermatologic Reactions to Targeted Therapy
- Non-hemorrhage-related adverse effects of rivaroxaban
- A study on dermatoses of pregnancy
- Psychoactive drugs and skin
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Anaemia and skin disease
- Drug eruptions in dermatology
- An overview of zinc and its importance in dermatology-Part II: The association of zinc with some dermatologic disorders
- Dermatosis associated with menopause
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Molecular Genetics of Alopecias
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Case report: pemphigus vulgaris in an adolescent
- Multiple minute digitate hyperkeratosis
- Growth factors IGF-1 and KGF and adipose-derived stem cells promote migration and viability of primary human keratinocytes in an in vitro wound model
- Skin disorders associated with the COVID‐19 pandemic: A review
- White piedra caused by <i>Trichosporon inkin</i> : a report of two cases in a northern climate
- Post‐traumatic erosive dermatosis of the scalp: A hypergranulated variant
- Viable terminal scalp hair follicles constitute a necessary and sufficient biological end‐organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles